Glycobiology Goes to the Ball

There's more to life than DNA, RNA, and proteins. Literally. Sugars are also in the mix. And the roles that carbohydrates play in biology are just as important as those of any member of the better-characterized trinity. These macromolecules affect cell-cell interactions, immune function, and protein regulation, and disruption of their biology results in disease. One magazine likened the study of carbohydrates, called glycobiology, to Cinderella—neglected stepsister to her two more glamoro

Written byJeffrey Perkel
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

One magazine likened the study of carbohydrates, called glycobiology, to Cinderella—neglected stepsister to her two more glamorous siblings, DNA and protein.1 Momentum is building, however, to do for carbohydrates what scientists have done for genomes, and are attempting to do for proteomes: to characterize the entire complement of these sugar chains in a cell, called the "glycome." Researchers are guardedly optimistic. According to Ajit Varki, professor of medicine and cell and molecular biology, and director of the Glycobiology Research and Training Center at the University of California, San Diego, "we don't know what's going to happen to Cinderella at midnight."

Scientists acknowledge that sequencing the genome was nothing compared to solving the proteome. Likewise, the glycome will make the proteome seem like child's play. "The problem is that [the glycome is] probably thousands of times as complicated as the genome, in magnitude of complexity and level of diversity," says Varki. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies